Cardiovascular Diseases Research in Minnesota
Cardiovascular Diseases Research (93.837) awarded $309 million to recipients in Minnesota in 265 grants from fiscal 2021 to 2025, 2.1% of the program's national total. Regents of the University of Minnesota received the most, $145 million.
- Awarded in Minnesota$309 million
- Awards265
- Share of the program2.1%
- Rank among states17th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 142 | $65.9 million |
| FY 2022 | 143 | $69.1 million |
| FY 2023 | 126 | $60.3 million |
| FY 2024 | 135 | $58.9 million |
| FY 2025 | 130 | $54.6 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Minnesota | Colleges and universities | 124 | $145 million |
| Mayo Clinic Jacksonville (a Nonprofit Corporation) | Nonprofits | 107 | $136 million |
| Minnesota Healthsolutions Corporation | Small businesses | 8 | $7.5 million |
| National Biomedical, LLC | Businesses | 2 | $4.1 million |
| Hennepin Healthcare Research Institute | Nonprofits | 2 | $3.3 million |
| Advancedcpr Solutions LLC | Small businesses | 3 | $2.8 million |
| Koronis Biomedical Technologies Corp. | Small businesses | 2 | $2.7 million |
| Imbio LLC | Small businesses | 3 | $1.6 million |
| Healthpartners Institute | Nonprofits | 1 | $1.3 million |
| Quench Medical Inc. | Small businesses | 2 | $1.1 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Minnesota?
$309 million from fiscal 2021 to 2025, across 265 awards. Minnesota ranks 17th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Minnesota?
The largest recipient is Regents of the University of Minnesota, with $145 million in 124 awards. Next are Mayo Clinic Jacksonville (a Nonprofit Corporation) and Minnesota Healthsolutions Corporation.
Can organizations in Minnesota apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative